Psychosis and schizophrenia in children and young people: recognition and management

Evidence update

Surveillance report

2023 exceptional surveillance of psychosis and schizophrenia in children, young people and adults (NICE guidelines CG155 and CG178)

Appendix A: PICO table for weight management searches (PDF 305 KB)

Appendix B: Summary of evidence (PDF 398 KB)

2023 exceptional surveillance of psychosis and schizophrenia in children and young people: recognition and management (NICE guideline CG155)

Appendix A: Equality and health inequalities assessment template  (PDF 175 KB)

2022 surveillance of psychosis and schizophrenia in children and young people: recognition and management (NICE guideline CG155)

Appendix A: Summary of evidence from surveillance (PDF 572 KB)

Appendix B: Stakeholder consultation comments table  (PDF 548 KB)

2021 exceptional surveillance of testing for diabetes (NICE guidelines CG178, CG185, CG155, CG158 and NG185)

Appendix A: Changes to recommendations on testing for diabetes across NICE guidelines (PDF 143 KB)

Surveillance report 2016 – Psychosis and schizophrenia in children and young people: recognition and management (2013) NICE guideline CG155

Appendix A: Summary of new evidence  (PDF 488 KB)

Appendix B: Stakeholder consultation comments (PDF 203 KB)

Full guidance

Addendum (PDF 1.95 MB)

Appendix 8 - Search strategies for the identification of clinical studies (PDF 333 KB)

Appendix 10 - Search strategies for the identification of health economic evidence (PDF 130 KB)

Appendix 15 - Economic evidence (completed methodology checklists) (PDF 198 KB)

Appendix 16 - Economic evidence (evidence tables of published studies) (PDF 198 KB)

Appendix 13a - Clinical evidence study characteristics tables: At risk mental states for psychosis and schizophrenia in children and young people (PDF 349 KB)

Appendix 13b - Clinical evidence study characteristics tables: Psychological and psychosocial interventions (PDF 504 KB)

Appendix 13c - Clinical evidence study characteristics tables: Pharmacological interventions (PDF 1.28 MB)

Appendix 13d - Clinical evidence study characteristics tables: Cognition, employment and education (PDF 278 KB)

Appendix 14a - Clinical evidence forest plots: At risk mental states for psychosis and schizophrenia in children and young people (PDF 450 KB)

Appendix 14b - Clinical evidence forest plots: Psychological and psychosocial interventions (PDF 274 KB)

Appendix 14c - Clinical evidence forest plots: Pharmacological interventions (PDF 1.04 MB)

Appendix 14d - Clinical evidence forest plots: Cognition, employment and education (PDF 165 KB)

Appendix 17a - Clinical evidence profiles: At risk mental states for psychosis and schizophrenia in children and young people (PDF 899 KB)

Appendix 17b - Clinical evidence profiles: Psychological and psychosocial interventions (PDF 526 KB)

Appendix 17c - Clinical evidence profiles: Pharmacological interventions (PDF 2.1 MB)

Appendix 17d - Clinical evidence profiles: Cognition, employment and education (PDF 406 KB)